Nutriband Inc.

Contributing Author

Recent Articles by Nutriband Inc.

Sep-22	Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing NTRB -13.00% GlobeNewswire
Sep-09	Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit NTRB GlobeNewswire
Sep-08	Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Aug-13	Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight NTRB GlobeNewswire
May-15	Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference NTRB GlobeNewswire
Apr-22	Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast NTRB GlobeNewswire
Mar-30	Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch NTRB -10.36% GlobeNewswire
Mar-18	Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica NTRB GlobeNewswire
Feb-17	Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica NTRB GlobeNewswire
Feb-17	Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica NTRB GlobeNewswire
Jan-30	Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points NTRB +5.97% GlobeNewswire
Dec-31	Nutriband CEO Publishes Letter to Shareholders NTRB GlobeNewswire
Dec-29	Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio NTRB +16.04% GlobeNewswire
Dec-18	Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration NTRB GlobeNewswire
Dec-18	Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction NTRB GlobeNewswire
Oct-28	REPEAT - Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch NTRB +10.38% GlobeNewswire
Oct-28	Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch NTRB +10.38% GlobeNewswire
Oct-27	Nutriband Co-Founder Gareth Sheridan Returns as CEO NTRB GlobeNewswire
Oct-10	Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch NTRB -5.06% GlobeNewswire
Oct-08	Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology NTRB +8.42% GlobeNewswire
Oct-08	Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference NTRB +8.42% GlobeNewswire
Sep-24	Nutriband Inc. to Present at the MicroCap Rodeo Conference NTRB GlobeNewswire
Sep-10	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB GlobeNewswire
Sep-03	Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 NTRB GlobeNewswire
Aug-18	Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 NTRB GlobeNewswire
Aug-11	Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election NTRB GlobeNewswire
Aug-08	FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jul-18	Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval NTRB GlobeNewswire
Jul-02	Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval NTRB +33.67% GlobeNewswire
Jul-01	Nutriband Inc. added to the Russell Microcap Index, Russell Microcap Growth Index, Russell 3000E Index and Russell 3000E Growth Index NTRB GlobeNewswire
Jun-18	Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jun-09	Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology NTRB GlobeNewswire
Jun-03	Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference NTRB GlobeNewswire
Jun-02	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB +24.77% GlobeNewswire

Nutriband Inc.

Recent Articles by Nutriband Inc.

Upgrade your Finviz experience